| 英文名称 |
中文名称 |
CAS号 |
操作 |
| PH-064 |
892546-37-1 |
892546-37-1 |
详细
|
| SGA360 |
SGA360 |
680611-86-3 |
详细
|
| AA 41612 |
化合物AA41612 |
433690-62-1 |
详细
|
| SR-3029 |
SR-3029 |
1454585-06-8 |
详细
|
| Creatine riboside |
Creatine riboside |
1616693-92-5 |
详细
|
| (S)-3,4-DCPG |
(S)-3,4-二甲酸苯基甘氨酸 |
201730-11-2 |
详细
|
| MSBN |
MSBN |
135980-66-4 |
详细
|
| DL5H3 |
1-Piperidinepropanamide, N-[1,2,3,9-tetrahydro-9-oxo-3-(phenylmethylene)pyrrolo[2,1-b]quinazolin-6-yl]- |
90263-34-6 |
详细
|
| GSK3 Inhibitor XIII |
N-(5-甲基-1H-吡唑-3-基)-2-苯基-4-喹唑啉胺 |
404828-14-4 |
详细
|
| Ribocil |
1381289-58-2 |
1381289-58-2 |
详细
|
| SGC2085 |
SGC2085.HCL |
1821908-49-9 |
详细
|
| BMS 986187 |
BMS 986187 |
684238-37-7 |
详细
|
| LOC14 |
2-((4-(环丙烷羰基)哌嗪-1-基)甲基)苯并[D]异噻唑-3(2H)-酮 |
877963-94-5 |
详细
|
| RG7834 |
RO 7020322 |
2072057-17-9 |
详细
|
| 2-(nitroimino)imidazolidine |
|
54565-96-3 |
详细
|
| NS13001 |
N-(4-氯苯基)-2-(3,5-二甲基-1H-吡唑-1-基)-9-甲基-9H-嘌呤-6-胺 |
1063331-94-1 |
详细
|
| BGC-20-1531 |
BGC-20-1531 |
1186532-61-5 |
详细
|
| AEM1 |
AEM1 |
1030123-90-0 |
详细
|
| GSK121 trifluoroacetate |
GSK121 (trifluoroacetate salt) |
1652591-80-4 |
详细
|
| WAY-169916 |
1,3-Benzenediol, 4-[1-(2-propenyl)-7-(trifluoromethyl)-1H-indazol-3-yl]- |
669764-18-5 |
详细
|
| pyrimorph |
丁吡吗啉 |
868390-90-3 |
详细
|
| NCGC00262650 |
NCGC00262650 |
344359-25-7 |
详细
|
| Takeda103A |
Takeda103A |
865609-72-9 |
详细
|
| (R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-
((methylamino)methyl)phenyl)thiophen-2-
yl)ethyl)quinazolin-4-amine |
(R)-6,7-二甲氧基-2-甲基-N-(1-(4-(2-((甲基氨基)甲基)苯基)噻吩-2-基)乙基)喹唑啉-4-胺 |
2244904-70-7 |
详细
|
| Soporidine |
化合物SOPORIDINE |
1060376-43-3 |
详细
|
| VPC-80051 |
1H-Indazole-3-carboxamide, N-[1-(3,4-difluorophenyl)ethyl]- |
877969-69-2 |
详细
|
| AH-3960 |
化合物AH-3960 |
862907-48-0 |
详细
|
| Imidacloprid-urea |
甲醇中吡虫啉-尿素溶液,100ΜG/ML |
120868-66-8 |
详细
|
| N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
详细
|
| APS-2-79 |
2002381-25-9 |
2002381-25-9 |
详细
|
| GNE-140 racemate |
GNE140 racemate |
1802977-61-2 |
详细
|
| TMP778 |
化合物TMP-778 |
1422171-08-1 |
详细
|
| Epiblastin A |
Epiblastin A |
16470-02-3 |
详细
|
| TTK21 |
TTK21 |
709676-56-2 |
详细
|
| pythiDC |
化合物PYTHIDC |
1821370-71-1 |
详细
|
| CB38231393 |
2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- |
1481401-71-1 |
详细
|
| Org24448, CX-691 |
CX691 |
211735-76-1 |
详细
|
| 1-(5-bromo-2-chlorobenzyl)-4-(4-methoxybenzyl)piperazine |
|
|
详细
|
| AGK2 |
2-氰基-3-[5-(2,5-二氯苯基)-2-呋喃基]-N-5-喹啉基-2-丙烯酰胺 |
304896-28-4 |
详细
|
| ONO-8130 |
ONO-8130 |
459841-96-4 |
详细
|
| FIN56 |
FIN56 |
1083162-61-1 |
详细
|
| RH01687 |
RH01687 |
302901-13-9 |
详细
|
| AF64394 |
CS-2866 |
1637300-25-4 |
详细
|
| BMS 986188 |
BMS 986188 |
1776115-10-6 |
详细
|
| GSK199 |
GSK199;GSK 199 |
1549811-53-1 |
详细
|
| TSPC |
TSPC |
882286-32-0 |
详细
|
| RU.521
RU320521 |
RU320521 |
2262452-06-0 |
详细
|
| 1-Propanone, 1-[(5R)-4,5-dihydro-5-phenyl-1H-pyrazol-1-yl]-2,2-dimethyl- |
GSK962（R构型） |
2049872-86-6 |
详细
|
| (S)-SHA 68 |
|
847555-75-3 |
详细
|
| MH-26774 |
|
|
详细
|
| Cytosporone B |
CSN-B |
321661-62-5 |
详细
|
| WWL229 |
WWL229 |
1338575-28-2 |
详细
|
| RO5203648 HCl |
RO-5203648 |
1043491-54-8 |
详细
|
| DD1 |
化合物DD1 |
187585-11-1 |
详细
|
| RY785 |
化合物RY785 |
689297-68-5 |
详细
|
| Shield-1 Tosylate |
化合物SHIELD-1 |
914805-33-7 |
详细
|
| NCGC607 |
NCGC607 |
1462267-07-7 |
详细
|
| R243 |
R243 |
688352-84-3 |
详细
|
| TM2-115 |
TM2-115 |
1197196-47-6 |
详细
|
| N-(4-ethynylphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide |
化合物ML198 |
1380716-06-2 |
详细
|
| ALE-0540 |
ALE-0540 |
234779-34-1 |
详细
|
| IMIDACLOPRID IMPURITY 1 |
吡虫啉杂质1 |
105828-41-9 |
详细
|
| ERDRP-0519 |
ERDRP-0519 |
1374006-96-8 |
详细
|
| Methyl 4-((2-(piperidin-1-ylmethyl)-1H-benzo[d]imidazol-
5-yl)carbamoyl)benzoate |
4-((2-(哌啶-1-基甲基)-1H-苯并[D]咪唑-5-基)氨基甲酰基)苯甲酸酯 |
|
详细
|
| GSK864 |
1816331-66-4 |
1816331-66-4 |
详细
|
| CU-CPT-8m |
CPD1578 |
125079-83-6 |
详细
|
| A-485 |
1889279-16-6 |
1889279-16-6 |
详细
|
| ML 349 |
APT-2抑制剂 |
890819-86-0 |
详细
|
| ML226 |
ML-226 |
2055172-43-3 |
详细
|
| gboxin |
Gboxin |
2101315-36-8 |
详细
|
| squarunkin A |
化合物SQUARUNKINA |
2101958-02-3 |
详细
|
| AZ617 |
|
2247439-36-5 |
详细
|
| Flupenthixol dihydrochloride |
顺式-(Z)-氟哌噻吨二盐酸盐 |
51529-01-2 |
详细
|
| SC-57461A |
N -甲基- N -[3 - [4 - (苯甲基)苯氧基]丙基Β-丙氨酸盐酸盐 |
423169-68-0 |
详细
|
| TC-S 7001 |
6-氯-N4-[3,5-二氟-4-[(3-甲基-1H-吡咯并[2,3-B]吡啶-4-基)氧]苯基]-2,4-嘧啶二胺 |
867017-68-3 |
详细
|
| SHA 68 |
SHA 68 |
847553-89-3 |
详细
|
| BRD6688 |
BRD6688 |
1404562-17-9 |
详细
|
| CMPD101 |
CMPD101 |
865608-11-3 |
详细
|
| SRI-011381 |
SRI011381 |
1629138-41-5 |
详细
|
| CIL56 |
2,7-双(哌啶-1-基磺酰基)-9H-芴-9-酮肟 |
300802-28-2 |
详细
|
| KLH45 |
KLH45 |
1632236-44-2 |
详细
|
| FT671 |
化合物 T12621L |
1959551-26-8 |
详细
|
| T3 |
CLK inhibitor T3
(T3) |
2109805-56-1 |
详细
|
| 2-(Aminosulfonyl)benzoic acid |
邻磺酰胺苯甲酸 |
632-24-6 |
详细
|
| iGOT1-01 |
化合物IGOT1-01 |
882256-55-5 |
详细
|
| GI254023X |
(ALPHAR)-N-[(1S)-2,2-二甲基-1-[(甲基氨基)羰基]丙基]-ALPHA-[(1S)-1-(甲酰基羟基氨基)乙基]苯戊酰胺 |
260264-93-5 |
详细
|
| ML311 |
315698-17-0 |
315698-17-0 |
详细
|
| PF-794 |
PF-794 |
2056111-45-4 |
详细
|
| ML246 |
METARRESTIN |
1443414-10-5 |
详细
|
| Aka Lumine |
AKA LUMINE |
1176235-08-7 |
详细
|
| PS 210 |
PS 210 |
1221962-86-2 |
详细
|
| AS1842856 |
5-氨基-7-(环己基氨基)-1-乙基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸 |
836620-48-5 |
详细
|
| GSK106 hydrochloride |
GSK106 (hydrochloride) |
1652591-82-6 |
详细
|
| NSC45586 |
Benzoic acid,5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-,sodium salt (1:1) |
6300-44-3 |
详细
|
| LP99 |
化合物LP99 |
1808951-93-0 |
详细
|
| Desketoraloxifene |
Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenyl]- |
216570-81-9 |
详细
|
| 7-Amino-4-chloro-3-propoxy-isochromen-1-one |
化合物 T25549 |
126062-19-9 |
详细
|
| (S)-2,2-dimethyl-1-(5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)propan-1-one |
GSK963（S构型） |
2049868-46-2 |
详细
|
| OSMI 1 |
OSMI-1 |
1681056-61-0 |
详细
|
| MN58b |
化合物MN58B |
203192-01-2 |
详细
|